Overview

Effect of Nebulized Bronchodilators on Heart Rate

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to determine adverse events rates of nebulized albuterol versus levalbuterol among adult critically ill patients and determine if a differential exists in adverse events between the two drugs.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Fahim Khorfan, MD
Collaborators:
Ascension Genesys Hospital
Genesys Regional Medical Center
Treatments:
Albuterol
Bronchodilator Agents
Ipratropium
Criteria
Inclusion Criteria:

- Adults who required inhaled bronchodilator therapy in the form of short acting beta
adrenergic receptor agonist and short acting anti-cholinergic treatment every 4-6
hours for respiratory functions

Exclusion Criteria:

- Known allergy or sensitivity to study medications

- Baseline heart rate was greater than 110 beats per minute